Burning Rock Biotech (BNR) Current Assets (2019 - 2026)

Burning Rock Biotech (BNR) has reported Current Assets for 8 consecutive years, with $101.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Current Assets fell 3.16% year-over-year to $101.6 million; the TTM figure through Mar 2026 stood at $101.6 million (down 3.16% YoY), while the FY2025 annual figure was $105.6 million, down 0.73% from the prior year.
• Current Assets came in at $101.6 million for Q1 2026 at Burning Rock Biotech, down from $104.1 million in the prior quarter.
• The five-year high for Current Assets was $265.9 million in Q1 2022, with the low at $101.6 million in Q1 2026.
• Average Current Assets over 5 years is $140.5 million, with a median of $116.5 million recorded in 2024.
• Across the five-year window, Current Assets slumped 38.44% in 2022 and slipped 3.16% in 2026, its largest moves.
• Year by year, Current Assets stood at $177.0 million in 2022, then plunged by 30.62% to $122.8 million in 2023, then decreased by 11.95% to $108.1 million in 2024, then dropped by 3.68% to $104.1 million in 2025, then retreated by 2.41% to $101.6 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $101.6 million, $104.1 million, and $103.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.